Analyst Price Targets — DXCM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 2:04 pm | — | Truist Financial | $87.00 | $77.61 | TheFly | DexCom price target raised to $87 from $80 at Truist |
| June 23, 2026 11:41 am | — | Deutsche Bank | $86.00 | $69.07 | TheFly | DexCom initiated with a Buy at Deutsche Bank |
| June 15, 2026 10:37 am | Matt O'Brien | Piper Sandler | $88.00 | $75.37 | TheFly | DexCom price target raised to $88 from $75 at Piper Sandler |
| June 10, 2026 12:30 pm | — | UBS | $95.00 | $78.42 | StreetInsider | DexCom (DXCM) PT Raised to $95 at TD Cowen as 'CONNECT and MACE Data Impress at ADA' |
| June 9, 2026 10:41 am | Anthony Petrone | Mizuho Securities | $85.00 | $76.62 | StreetInsider | DexCom (DXCM) PT Raised to $85 at Mizuho |
| June 8, 2026 7:15 pm | — | Raymond James | $91.00 | $76.62 | TheFly | DexCom price target raised to $91 from $81 at Raymond James |
| June 5, 2026 11:00 am | Jonathan Block | Stifel Nicolaus | $90.00 | $72.59 | TheFly | DexCom price target raised to $90 from $85 at Stifel |
| May 18, 2026 11:09 am | — | Canaccord Genuity | $82.00 | $61.63 | TheFly | DexCom price target lowered to $82 from $100 at Canaccord |
| May 18, 2026 9:42 am | Matt Miksic | Barclays | $64.00 | $61.63 | TheFly | DexCom price target lowered to $64 from $67 at Barclays |
| May 1, 2026 1:12 pm | — | Bernstein | $77.00 | $61.03 | TheFly | DexCom price target lowered to $77 from $83 at Bernstein |
Latest News for DXCM
DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real‑time glucose readings…
[url="]DexCom, Inc.[/url] (NASDAQ: DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.